Efficacy of 5 Years of Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B Patients With High Viral Load (HBV DNA ≥9 Log10 Copies/Ml)

被引：0
|
作者：
Gordon, Stuart C.
Marcellin, Patrick
Krastev, Zahary
Horban, Andrzej
Petersen, Joerg
Sperl, Jan
Phillip Dinh
Martins, Eduardo B.
Yee, Leland J.
Flaherty, John F.
Kitrinos, Kathryn M.
Rustgi, Nika Berger Vinod K.
Heathcote, Jenny
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S954 / S954
页数：1
相关论文
共 50 条
  • [1] 4 YEAR EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B PATIENTS WITH HIGH VIRAL LOAD (HBV DNA ≥9 LOG10 COPIES/ML): PRELIMINARY ANALYSIS
    Gordon, Stuart C.
    Marcellin, Patrick
    Krastev, Zahary
    Horban, Andrzej
    Petersen, Joerg
    Sperl, Jan
    Rustgi, Vinod K.
    Heathcote, E. Jenny
    Mondou, Elsa
    Coombs, Derek H.
    Anderson, Jane
    HEPATOLOGY, 2010, 52 (04) : 388A - 388A
  • [2] Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)
    Fung, Scott
    Gordon, Stuart C.
    Krastev, Zahary
    Horban, Andrzej
    Petersen, Joerg
    Sperl, Jan
    Gane, Edward
    Jacobson, Ira M.
    Yee, Leland J.
    Dinh, Phillip
    Martins, Eduardo B.
    Flaherty, John F.
    Kitrinos, Kathryn M.
    Dusheiko, Geoffrey
    Trinh, Huy
    Flisiak, Robert
    Rustgi, Vinod K.
    Buti, Maria
    Marcellin, Patrick
    LIVER INTERNATIONAL, 2015, 35 (02) : 422 - 428
  • [3] Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load
    Gordon, Stuart C.
    Krastev, Zahary
    Horban, Andrzej
    Petersen, Joerg
    Sperl, Jan
    Dinh, Phillip
    Martins, Eduardo B.
    Yee, Leland J.
    Flaherty, John F.
    Kitrinos, Kathryn M.
    Rustgi, Vinod K.
    Marcellin, Patrick
    HEPATOLOGY, 2013, 58 (02) : 505 - 513
  • [4] TWO YEARS SAFETY AND EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN PATIENTS WITH HBV-INDUCED CIRRHOSIS
    Buti, M.
    Hadziyannis, S.
    Mathurin, P.
    Urbanek, P.
    Sherman, M.
    Strasser, S.
    Wang, C.
    Petersen, J.
    Heathcote, E. J.
    Marcellin, P.
    Sorbel, J.
    Mondou, E.
    Anderson, J.
    Rousseau, F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S10 - S11
  • [5] Two years safety and efficacy of tenofovir disoproxil fumarate (TDF) in patients with HBV-induced cirrhosis
    Strasser, S. I.
    Gane, E. J.
    Weilert, F.
    Sievert, W.
    George, J.
    Crawford, D.
    Ngu, M. C.
    Heathcote, E. J.
    Marcellin, P.
    Sorbel, J.
    Rousseau, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A309 - A309
  • [6] Two Years Safety and Efficacy of Tenofovir Disoproxil Fumarate (TDF) in Patients with HBV-Induced Cirrhosis
    Buti, Maria
    Hadziyannis, Stephanos J.
    Mathurin, Philippe
    Urbanek, Petr
    Sherman, Morris
    Strasser, Simone I.
    Wang, Chia C.
    Petersen, Joerg
    Heathcote, Jenny
    Marcellin, Patrick
    Sorbel, Jeff
    Mondou, Elsa
    Anderson, Jane
    Rousseau, Franck
    GASTROENTEROLOGY, 2009, 136 (05) : A865 - A866
  • [7] Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
    Liaw, Yun-Fan
    Sheen, I-Shyan
    Lee, Chuan-Mo
    Akarca, Ulus Salih
    Papatheodoridis, George V.
    Wong, Florence Suet-Hing
    Chang, Ting-Tsung
    Horban, Andrzej
    Wang, Chia
    Kwan, Peter
    Buti, Maria
    Prieto, Martin
    Berg, Thomas
    Kitrinos, Kathryn
    Peschell, Ken
    Mondou, Elsa
    Frederick, David
    Rousseau, Franck
    Schiff, Eugene R.
    HEPATOLOGY, 2011, 53 (01) : 62 - 72
  • [8] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) VS TENOFOVIR DISOPROXIL FUMARATE (TDF) IN EAST ASIAN CHRONIC HEPATITIS B PATIENTS FOLLOWING 5-YEARS OF TREATMENT
    Wong, Grace Lai Hung
    Gane, Edward
    Pan, Calvin
    Lim, Young-Suk
    Fung, Scott
    Izumi, Namiki
    Ma, Mang
    Chan, Carol Yee Kwan
    Shalimar, Dr
    Buti, Maria
    GUT, 2021, 70 : A76 - A76
  • [9] Safety and efficacy in lamivudine (LAM) experienced chronic hepatitis B (CHB) patients treated for 2 years with tenofovir disoproxil fumarate (TDF)
    Roberts, S. K.
    Gane, E. J.
    Weilert, F.
    Sievert, W.
    George, J.
    Strasser, S. I.
    Kronborg, I.
    Heathcote, E. J.
    Marcellin, P.
    Sorbel, J.
    Rousseau, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A299 - A299
  • [10] Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients.
    Benhamou, Y
    Piketty, C
    Katlama, C
    Rozembaum, W
    Neau, D
    Lafeuillade, A
    Rey, D
    Yazdanpanah, Y
    Trimoulet, P
    Fleury, H
    HEPATOLOGY, 2003, 38 (04) : 712A - 713A
12345